GM

Gopikrishna Moku

Kakatiya Institute of Technology and Science, University of Minnesota

ORCID iD 0000-0001-5980-0537
Follow

Employment

  • Kakatiya Institute of Technology and Science
    2019 - Present
  • University of Minnesota
    2016 - 2019

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

  • In vivo targeting of liposomally complexed DNA vaccines to dendritic cells induce long lasting protection against melanoma tumor
    2020
    +Save
  • Mesenchymal stem cells engineered with TAT peptide functionalized nanoparticles improve therapeutic efficacy of paclitaxel in an orthotopic lung tumor model
    2019
    +Save
  • Surface Modification of Nanoparticles: Methods and Applications
    2019
    +Save
  • Cell Penetrating Peptide TAT Increases Cellular Uptake of PLGA Nanoparticles in Mesenchymal Stem Cells
    Industrial Partners for Research in Interfacial and Materials Engineering (IPRIME) Annual Meeting, Minneapolis, Minnesota, USA 2017
    +Save
  • Mannose-receptor selective lysinylated cationic amphiphiles and a process for preparation thereof
    2017
    +Save
  • Histidinylated cationic amphiphiles, process for preparation therof and their liposomal formulation
    2015
    +Save
  • Dramatically Long Lasting Protection against Melanoma Tumor through Liposomal Targeting of DNA Vaccines to Dendritic Cells
    International Knowledge Millennium Conference” (IKMC), November 2014, HICC, Hyderabad, India 2014
    +Save
  • Evidence for Significant Tumor Growth Inhibition Properties of Endosomal pH- Sensitive Cationic Liposomes: A Serendipitous Discovery
    International Conference on Chemical Biology (ICCB) February 2014, CSIR-IICT, Hyderabad, India 2014
    +Save
  • Eradication of Established Hepatocellular Carcinoma by Targeted Chemotherapy and In vivo dendritic cell targeted DNA vaacination
    4 th annual Cell and Gene Therapy Symposium” organized by Centre for Stem Cell Research, Christian Medical College Campus, Bagayam, Vellore, September 2019.
    +Save
  • In vivo Targeting of DNA Vaccines to Dendritic Cells induce anti tumor immune response against melanoma tumor
    +Save